---
title: Dr Benjamin Toh
permalink: /biography/board-oversight-committee/dr-benjamin-toh/
variant: tiptap
description: ""
third_nav_title: Board Oversight Committee
---
<h3>Dr Benjamin Toh</h3>
<p></p>
<div class="isomer-image-wrapper">
<img style="width: 40%;" height="auto" width="100%" alt="" src="/images/Biography/Board Oversight Committee/Dr_Benjamin_Toh.png">
</div>
<h4>Affiliations</h4>
<p>Executive Director (Bioeconomy, Biomedical Research Council), Agency for
Science, Technology and Research</p>
<h4>Profile</h4>
<p>Dr. Benjamin Toh serves as the Executive Director of the Biomedical Research
Council (BMRC) at A*STAR. In this capacity, he spearheads the implementation
of A*STAR’s strategies and initiatives in therapeutics discovery and biomanufacturing,
aiming to generate significant industry and societal impact while building
long-term R&amp;D capabilities for Singapore. Concurrently, Dr. Toh is
the Programme Director of A*STAR’s Cell and Gene Therapy Flagship Programme,
where his team collaborates closely with A*STAR’s Research Institutes and
other public sector researchers to develop research programmes that address
national and industry needs.&nbsp;</p>
<p>With over 15 years of experience in biomedical R&amp;D, Dr. Toh has dedicated
the majority of his career to R&amp;D strategy and programme development.
Previously, he was the Principal Business Analyst for Advanced MedTech,
a MedTech company headquartered in Singapore, where he supported strategic
business planning and business development. He also served as the Director
of Strategic Planning at BMRC, leading the development and implementation
of A*STAR’s Health and Biomedical Sciences strategic plans and corporate
policies.&nbsp;</p>
<p>Dr. Toh earned his Doctor of Philosophy from the NUS Graduate School for
Integrative Sciences and Engineering, focusing his research on cancer immunology
and antibody discovery.</p>